{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:53:45Z","timestamp":1781042025194,"version":"3.54.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"DOI":"10.1093\/ndt\/gfl146","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T00:25:23Z","timestamp":1144196723000},"page":"2217-2224","source":"Crossref","is-referenced-by-count":135,"title":["Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up"],"prefix":"10.1093","volume":"21","author":[{"given":"Goce B.","family":"Spasovski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Sikole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saso","family":"Gelev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelka","family":"Masin-Spasovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Freemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"De Broe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C.","family":"D'Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,4,4]]},"reference":[{"key":"key\n\t\t\t\t20171013011951_BIB1","doi-asserted-by":"crossref","unstructured":"Llach F, Coburn JW. Renal osteodystrophy and maintenance dialysis. In: Maher JF, ed. Replacement of Renal Function by Dialysis, 3rd edn, Kluwer Academic Publishers, Dordrecht\/Boston\/Lancaster: 1989; 911\u2013952","DOI":"10.1007\/978-94-009-1087-4_44"},{"key":"key\n\t\t\t\t20171013011951_BIB2","doi-asserted-by":"crossref","unstructured":"Spasovski G, Bervoets A, Behets G et al. Spectrum of renal bone disease in end-stage renal failure patients not in dialysis yet. Nephrol Dial Transplant2003; 18: 1159\u20131166","DOI":"10.1093\/ndt\/gfg116"},{"key":"key\n\t\t\t\t20171013011951_BIB3","unstructured":"Malluche HH, Monier-Faugere MC. Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow. Clin Nephrol2000; 54: 309\u2013317"},{"key":"key\n\t\t\t\t20171013011951_BIB4","doi-asserted-by":"crossref","unstructured":"Hsu CH, Patel S, Buchsbaum BL. Calcitriol metabolism in patients with chronic renal failure. Am J Kidney Dis1991; 17: 185\u2013190","DOI":"10.1016\/S0272-6386(12)81127-9"},{"key":"key\n\t\t\t\t20171013011951_BIB5","doi-asserted-by":"crossref","unstructured":"Goodman WG. Bone disease and aluminum: pathogenic considerations. Am J Kidney Dis1985; 6: 330\u2013335","DOI":"10.1016\/S0272-6386(85)80089-5"},{"key":"key\n\t\t\t\t20171013011951_BIB6","doi-asserted-by":"crossref","unstructured":"De Broe ME, Coburn JW. Aluminum and Renal Failure. In: Developments in Nephrology 26. Kluwer Academic Publishers, Dordrecht: The Netherlands, 1990: 99\u2013375","DOI":"10.1007\/978-94-009-1868-9"},{"key":"key\n\t\t\t\t20171013011951_BIB7","doi-asserted-by":"crossref","unstructured":"Goodman WG, Goldin J, Kuizon BD. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med2000; 342: 1478\u20131483","DOI":"10.1056\/NEJM200005183422003"},{"key":"key\n\t\t\t\t20171013011951_BIB8","doi-asserted-by":"crossref","unstructured":"Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypert2001; 10: 563\u2013568","DOI":"10.1097\/00041552-200109000-00003"},{"key":"key\n\t\t\t\t20171013011951_BIB9","doi-asserted-by":"crossref","unstructured":"Kurz P, Monier-Faugere MC, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int1994; 46: 855\u2013861","DOI":"10.1038\/ki.1994.342"},{"key":"key\n\t\t\t\t20171013011951_BIB10","doi-asserted-by":"crossref","unstructured":"Chertow GM, Burke SK, Lazarus JM et al. Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis1997; 29: 66\u201371","DOI":"10.1016\/S0272-6386(97)90009-3"},{"key":"key\n\t\t\t\t20171013011951_BIB11","doi-asserted-by":"crossref","unstructured":"Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int2002; 62: 245\u2013252","DOI":"10.1046\/j.1523-1755.2002.00434.x"},{"key":"key\n\t\t\t\t20171013011951_BIB12","doi-asserted-by":"crossref","unstructured":"Hergesell O, Ritz E. Phosphate binders in uremia: pharmacodynamics, pharmacoeconomics, pharmacoethics. Nephrol Dial Transplant2002; 17: 14\u201317","DOI":"10.1093\/ndt\/17.1.14"},{"key":"key\n\t\t\t\t20171013011951_BIB13","doi-asserted-by":"crossref","unstructured":"Brezina B, Qunibi W, Nolan CR. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications. Kidney Int2004; 66: S39\u2013S45","DOI":"10.1111\/j.1523-1755.2004.09007.x"},{"key":"key\n\t\t\t\t20171013011951_BIB14","doi-asserted-by":"crossref","unstructured":"Gallieni M, Cozzolino M, Brancaccio D. Transient decrease of serum bicarbonate levels with sevelamer hydrochloride as the phosphate binder. Kidney Int2000; 57: 1776\u20131777","DOI":"10.1046\/j.1523-1755.2000.00025.x"},{"key":"key\n\t\t\t\t20171013011951_BIB15","doi-asserted-by":"crossref","unstructured":"Fournier A, Barsoum J, Fickl R et al. Sevelamer, Ca\u00d7P product and vitamin D. Nephrol Dial Transplant2001; 16: 429\u2013430","DOI":"10.1093\/ndt\/16.2.429"},{"key":"key\n\t\t\t\t20171013011951_BIB16","doi-asserted-by":"crossref","unstructured":"Joy MS, Finn WF. Randomized, double-blind, placebo-controlled, dose-titration, Phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am J Kidney Dis2003; 42: 96\u2013107","DOI":"10.1016\/S0272-6386(03)00554-7"},{"key":"key\n\t\t\t\t20171013011951_BIB17","doi-asserted-by":"crossref","unstructured":"Finn WF, Joy MS, Hladik G. Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis. Clin Nephrol2004; 62: 193\u2013201","DOI":"10.5414\/CNP62193"},{"key":"key\n\t\t\t\t20171013011951_BIB18","doi-asserted-by":"crossref","unstructured":"D'Haese PC, Spasovski G, Sikole A et al. Multi-centre study on the effects of lanthanum carbonate (Fosrenol\u00ae) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int2003; 63: S73\u2013S78","DOI":"10.1046\/j.1523-1755.63.s85.18.x"},{"key":"key\n\t\t\t\t20171013011951_BIB19","unstructured":"Pennick M, Damment SJP, Gill M. The pharmacokinetics and tissue distribution of lanthanum carbonate (Fosrenol), a new non-aluminum, non-calcium phosphate binder (Abstract). J Am Soc Nephrol2003; 14: 380A"},{"key":"key\n\t\t\t\t20171013011951_BIB20","doi-asserted-by":"crossref","unstructured":"Lacour B, Lucas A, Auchere D et al. Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int2005; 67: 1062\u20131069","DOI":"10.1111\/j.1523-1755.2005.00171.x"},{"key":"key\n\t\t\t\t20171013011951_BIB21","doi-asserted-by":"crossref","unstructured":"The World Medical Association. Declaration of Helsinki: http:\/\/www.wma.net\/e\/policy\/b3.htm2000","DOI":"10.4414\/fms.2001.04031"},{"key":"key\n\t\t\t\t20171013011951_BIB22","doi-asserted-by":"crossref","unstructured":"Spasovski GB. Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy. Int J Artif Organs2004; 27: 918\u2013923","DOI":"10.1177\/039139880402701103"},{"key":"key\n\t\t\t\t20171013011951_BIB23","doi-asserted-by":"crossref","unstructured":"Cueto-Manzo AM, Konel S, Hutchinson AJ et al. Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int1999; 55: 2021\u20132029","DOI":"10.1046\/j.1523-1755.1999.00445.x"},{"key":"key\n\t\t\t\t20171013011951_BIB24","doi-asserted-by":"crossref","unstructured":"Hutchison AJ, Whitehouse RW, Boulton HF et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int1993; 44: 1071\u20131077","DOI":"10.1038\/ki.1993.350"},{"key":"key\n\t\t\t\t20171013011951_BIB25","unstructured":"Pennick M, Damment SJP, Gill M. The new non-aluminum, non-calcium phosphate binder, lanthanum carbonate, demonstrates pharmacokinetics favourable for use in a chronic kidney disease population (Abstract). Proceedings, ERA-EDTA XLI Congress, 2004, SP 268"},{"key":"key\n\t\t\t\t20171013011951_BIB26","unstructured":"Jouhanneau P, Lacour B, Raisbeck G et al. Gastrointestinal absorption of aluminum in rats using 26Al and accelerator mass spectrometry. Clin Nephrol1993; 40: 244\u2013248"},{"key":"key\n\t\t\t\t20171013011951_BIB27","doi-asserted-by":"crossref","unstructured":"Priest ND, Talbot RJ, Austin JG et al. The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers. Biometals1996; 9: 221\u2013228","DOI":"10.1007\/BF00817919"},{"key":"key\n\t\t\t\t20171013011951_BIB28","doi-asserted-by":"crossref","unstructured":"Behets GJ, Verberckmoes SC, Oste L et al. Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate. Kidney Int2005; 67: 1830\u20131836","DOI":"10.1111\/j.1523-1755.2005.00281.x"},{"key":"key\n\t\t\t\t20171013011951_BIB29","doi-asserted-by":"crossref","unstructured":"D\u2019Haese PC, Couttenye MM, Lamberts LV et al. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem1999; 45: 1548\u20131556","DOI":"10.1093\/clinchem\/45.9.1548"},{"key":"key\n\t\t\t\t20171013011951_BIB30","unstructured":"Bervoets A, Dams G, Marynissen R et al. Effect of uremia on the gastrointestinal absorption of lanthanum (La)-carbonate (Abstract). J Am Soc Nephrol2005; 16: 748A"},{"key":"key\n\t\t\t\t20171013011951_BIB31","doi-asserted-by":"crossref","unstructured":"D\u2019Haese PC, Behets GJ, De Broe ME, Damment SJP. Lanthanum pharmacokinetics. Are rat data misleading (Letter to the Editor). Kidney Int2005; 68: 2907\u20132908","DOI":"10.1111\/j.1523-1755.2005.00583_3.x"},{"key":"key\n\t\t\t\t20171013011951_BIB32","doi-asserted-by":"crossref","unstructured":"Freemont T, Malluche HH. Utilization of bone histomorphometry in renal osteodystrophy: demonstration of a new approach using data from a prospective study of lanthanum carbonate. Clin Nephrol2005; 63: 138\u2013145","DOI":"10.5414\/CNP63138"},{"key":"key\n\t\t\t\t20171013011951_BIB33","doi-asserted-by":"crossref","unstructured":"Behets GJ, Dams G, Vercauteren SR et al. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? J Am Soc Nephrol2004; 15: 2219\u20132228","DOI":"10.1097\/01.ASN.0000133022.32912.95"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/8\/2217\/5153291\/gfl146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T14:22:12Z","timestamp":1586787732000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/8\/2217\/1820686\/Evolution-of-bone-and-plasma-concentration-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,4]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006,4,4]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl146","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,8]]},"published":{"date-parts":[[2006,4,4]]}}}